FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010506053> ?p ?o ?g. }

• W2010506053 abstract "Three etoposide-selected resistant sublines of the SuSa testicular teratoma cell line expressing 9-, 21- and 33-fold levels of resistance, proved increasingly cross resistant to cisplatin with levels approximating to 3-, 4- and 6-fold in sublines VPC2, VPC3 and VPC4, respectively. Cisplatin resistance was not associated with any significant modifications in levels of total glutathione or associated enzyme activities. Decreased platinum (Pt) accumulation was detected, although this did not correlate either with total platination levels judged immunochemically or with peak induction of interstrand crosslinks (ISC) determined by alkaline elution. Following exposure to cisplatin in the least resistant subline, VPC2, total platination levels were markedly decreased (3-fold) relative to those of the parental cells, whilst peak ISC levels were markedly increased (4-fold). In the most highly resistant subline, VPC4, peak levels of ISCs were even higher (9-fold), although total platination levels remained comparable with those in parental cells. Both VPC2 and VPC4 cells appeared highly proficient in removing ISCs, unlike the parental cells. However, whilst VPC2 cells appeared to share deficient removal of the intrastrand platinated lesions with parental cells, VPC4 cells proved proficient in removing specific adducts in the sequence pApG. This unusual expression of cross resistance to cisplatin in a series of etoposide-selected resistant sublines derived from an inherently repair deficient parental cell line, SuSa, therefore appears to be associated with enhanced removal of the specific intrastrand crosslinks in the sequence pApG and/or of DNA-DNA ISCs. Similar mechanisms have been implicated in two other cisplatin resistant SuSa sublines selected following in vitro exposure to the drug itself or to fractionated X-irradiation." @default.
• W2010506053 created "2016-06-24" @default.
• W2010506053 creator A5036886138 @default.
• W2010506053 creator A5055206007 @default.
• W2010506053 creator A5061922767 @default.
• W2010506053 date "1994-03-01" @default.
• W2010506053 modified "2023-09-27" @default.
• W2010506053 title "Characterization of the unusual expression of cross resistance to cisplatin in a series of etoposide-selected resistant sublines of the SuSa testicular teratoma cell line" @default.
• W2010506053 cites W1775749144 @default.
• W2010506053 cites W1977347251 @default.
• W2010506053 cites W2010004581 @default.
• W2010506053 cites W2024883189 @default.
• W2010506053 cites W2026182412 @default.
• W2010506053 cites W2026327431 @default.
• W2010506053 cites W2038170131 @default.
• W2010506053 cites W2046334666 @default.
• W2010506053 cites W2087184685 @default.
• W2010506053 cites W2107132176 @default.
• W2010506053 cites W2137211272 @default.
• W2010506053 cites W2151335450 @default.
• W2010506053 doi "https://doi.org/10.1016/0006-2952(94)90476-6" @default.
• W2010506053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8135853" @default.
• W2010506053 hasPublicationYear "1994" @default.
• W2010506053 type Work @default.
• W2010506053 sameAs 2010506053 @default.
• W2010506053 citedByCount "3" @default.
• W2010506053 crossrefType "journal-article" @default.
• W2010506053 hasAuthorship W2010506053A5036886138 @default.
• W2010506053 hasAuthorship W2010506053A5055206007 @default.
• W2010506053 hasAuthorship W2010506053A5061922767 @default.
• W2010506053 hasConcept C153911025 @default.
• W2010506053 hasConcept C181199279 @default.
• W2010506053 hasConcept C2776694085 @default.
• W2010506053 hasConcept C2778119113 @default.
• W2010506053 hasConcept C2778239845 @default.
• W2010506053 hasConcept C538909803 @default.
• W2010506053 hasConcept C54355233 @default.
• W2010506053 hasConcept C55493867 @default.
• W2010506053 hasConcept C81885089 @default.
• W2010506053 hasConcept C86803240 @default.
• W2010506053 hasConceptScore W2010506053C153911025 @default.
• W2010506053 hasConceptScore W2010506053C181199279 @default.
• W2010506053 hasConceptScore W2010506053C2776694085 @default.
• W2010506053 hasConceptScore W2010506053C2778119113 @default.
• W2010506053 hasConceptScore W2010506053C2778239845 @default.
• W2010506053 hasConceptScore W2010506053C538909803 @default.
• W2010506053 hasConceptScore W2010506053C54355233 @default.
• W2010506053 hasConceptScore W2010506053C55493867 @default.
• W2010506053 hasConceptScore W2010506053C81885089 @default.
• W2010506053 hasConceptScore W2010506053C86803240 @default.
• W2010506053 hasLocation W20105060531 @default.
• W2010506053 hasLocation W20105060532 @default.
• W2010506053 hasOpenAccess W2010506053 @default.
• W2010506053 hasPrimaryLocation W20105060531 @default.
• W2010506053 hasRelatedWork W173365041 @default.
• W2010506053 hasRelatedWork W1987145757 @default.
• W2010506053 hasRelatedWork W1997569032 @default.
• W2010506053 hasRelatedWork W2001575726 @default.
• W2010506053 hasRelatedWork W2010506053 @default.
• W2010506053 hasRelatedWork W2023927048 @default.
• W2010506053 hasRelatedWork W2039086504 @default.
• W2010506053 hasRelatedWork W2095370045 @default.
• W2010506053 hasRelatedWork W2353929735 @default.
• W2010506053 hasRelatedWork W2460083817 @default.
• W2010506053 isParatext "false" @default.
• W2010506053 isRetracted "false" @default.
• W2010506053 magId "2010506053" @default.
• W2010506053 workType "article" @default.